WS #10275

17:12→17:40 UTC
From 500 msgs · 5 key-dev

AbbVie reportedly in talks to buy a biotech for $10.9B for an experimental eczema drug, potentially boosting ABBV and the target.

AbbVie biotech acquisition target

AbbVie reportedly in talks to buy a biotech for $10.9B for an experimental eczema drug, potentially boosting ABBV and the target.

Full world state #10275 →

Strait of Hormuz conflicting reportsAI talent movement to Anthropic
← WS #10274WS #10276 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|